Delivery Order SPE2DB20D3304-SPE2DB25FW4L4

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,579.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is part of...
This federal contract award, valued at $14,475.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of March 3, 2025 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is a delivery order valued at $6,141.24 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price contract. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,758.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm fixed-price, delivery order contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This federal contract award, valued at $6,162.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of June 17, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $4,596.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 21, 2025. This award is not associated with a set-aside program and represents an open competition contract. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,132.12 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 27, 2023 and was awarded on October 26, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $13,158.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. This is a firm fixed-price delivery order contract with a period of performance through February 2025. The contract is not designated as a set-aside award. In addition to this specific delivery...
This federal contract award, valued at $2,859.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes, and has an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $31,200.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW4L4
    Delivery Order

This federal contract award, valued at $6,279.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract has a completion date of November 7, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:02 PM